Stroke (Cerebrovascular Accident): Clinical Breakdown: Pathophysiology, Ischemic vs. Hemorrhagic Classifications, Acute Clinical Presentation (FAST), and Management Principles
A clinical reference on stroke subtypes and their prevalence, the ischemic core and penumbra, excitotoxicity and delayed neuronal death, thrombolysis and thrombectomy, and secondary prevention.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- This is an accurate and well-structured clinical reference. The subtype table with its distinct acute interventions, and the core-and-penumbra explanation of why time matters, are both correct and clearly put. The notes below add the clinical detail around the mechanism.
- The time windows are the most important omission in a document about acute management. Thrombolysis is generally given within 4.5 hours of last known well. Thrombectomy has a standard window of 6 hours, extended to 24 hours in patients selected by perfusion imaging. These are not cliff edges: benefit declines continuously within the window, so earlier is better throughout.
- Last known well, rather than symptom discovery, is the reference point, because the time of arterial occlusion cannot be known. This matters for wake-up strokes, where imaging can now identify some patients who still benefit.
- The scale of neuronal loss makes the urgency concrete: a widely cited estimate is around 1.9 million neurons lost per minute in an untreated large-vessel ischemic stroke, roughly equivalent to ageing the affected brain by 3.6 years per hour.
- Thrombectomy deserves its evidence base. Five randomised trials reporting in 2015 showed substantial benefit for large vessel occlusion, with an unusually low number needed to treat for one additional independent outcome. Earlier negative trials used older devices and less precise patient selection, which is why the field reversed.
- The presentation section uses FAST. BE FAST, adding balance and eyes, was developed specifically because posterior circulation strokes were being missed. Vertigo, diplopia, dysarthria, dysphagia and ataxia are frequently attributed to vestibular causes, and the NIHSS under-scores these strokes, which compounds the problem.
- Sudden severe thunderclap headache belongs with the emergency presentations rather than among additional signs. It is the classic presentation of subarachnoid haemorrhage, and a sentinel bleed days earlier is commonly dismissed as migraine.
- Hyperacute management of haemorrhage is missing and is time-critical. Intracerebral haemorrhage commonly expands in the first hours; prompt blood pressure lowering reduces expansion, and urgent reversal of anticoagulation is among the most time-sensitive interventions available. Specific reversal agents exist for warfarin and for direct oral anticoagulants.
- On the diagnostic pathway: non-contrast CT is performed first principally to exclude haemorrhage, and an early ischemic stroke frequently appears normal on it, which is expected rather than reassuring. Glucose is checked immediately, because hypoglycaemia is the commonest and most rapidly correctable stroke mimic.
- Two additions to secondary prevention. Cause determines treatment: anticoagulation for cardioembolic stroke, antiplatelets otherwise, and the two are not interchangeable. And carotid revascularisation for symptomatic significant stenosis delivers most of its benefit when performed within two weeks.
- Finally, the single best-evidenced intervention across the whole stroke population is organised stroke unit care, which reduces death and dependency regardless of whether reperfusion treatment was given, and which benefits every patient rather than the minority who are eligible for acute therapy.
- Everything else in the brief is accurate: stroke as interruption or reduction of cerebral blood flow with infarction beginning within minutes; the subtype prevalences and their distinct acute interventions; thrombolytic therapy and endovascular thrombectomy for ischemic stroke; blood pressure stabilisation, anticoagulation reversal and neurosurgery for intracerebral haemorrhage; clipping or coiling with vasospasm management and intensive care for subarachnoid haemorrhage; the ischemic core and the salvageable penumbra; energy failure, membrane depolarisation, glutamate release, calcium influx and free radical generation driving delayed neuronal death; and secondary prevention through blood pressure control, antithrombotic therapy, statins, glycaemic management and neurorehabilitation.
Download the PDF
Our reviewed pages on this
All source documents